Overview

Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

Status:
Completed
Trial end date:
2017-11-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of the sedation for Remimazolam or Propofol in patients undergoing diagnostic upper GI endoscopy.
Phase:
Phase 3
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Propofol